ArticleBMJ open diabetes research & care2020

Oral administration of NPC43 counters hyperglycemia and activates insulin receptor in streptozotocin-induced type 1 diabetic mice.

Zi-Jian Lan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.